Pre-operative anaemia in patients undergoing major surgical procedures has been linked to poor outcomes. Therefore, early detection and treatment of pre-operative anaemia is recommended. However, to effectively implement a preoperative anaemia management protocol, an estimation of its prevalence and main causes is needed. We analysed data from 3342 patients (44.5% female) scheduled for either: elective orthopaedic surgery (n = 1286); cardiac surgery (n = 691); colorectal cancer resection (n = 735); radical prostatectomy (n = 362); gynaecological surgery (n = 203) or resection of liver metastases (n = 122). For both sexes, anaemia was defined by a haemoglobin level < 130 g.l
Summary
Pre-operative anaemia in patients undergoing major surgical procedures has been linked to poor outcomes. Therefore, early detection and treatment of pre-operative anaemia is recommended. However, to effectively implement a preoperative anaemia management protocol, an estimation of its prevalence and main causes is needed. We analysed data from 3342 patients (44.5% female) scheduled for either: elective orthopaedic surgery (n = 1286); cardiac surgery (n = 691); colorectal cancer resection (n = 735); radical prostatectomy (n = 362); gynaecological surgery (n = 203) or resection of liver metastases (n = 122). For both sexes, anaemia was defined by a haemoglobin level < 130 g.l
À1
; absolute iron deficiency by ferritin < 30 ng.ml À1 (< 100 ng.ml
, if transferrin saturation < 20% or C-reactive protein > 5 mg.l À1 ); iron sequestration by transferrin saturation < 20% and ferritin > 100 ng.ml
; and low iron stores by transferrin saturation > 20% and ferritin 30-100 ng.ml À1 . The overall prevalence of anaemia was 36%, with differences according to the type of surgery. Laboratory parameters allowing classification of iron status were available for 2884 patients. Among those with anaemia (n = 986), 677 (69%) were women, 608 (62%) presented with absolute iron deficiency, 101 (10%) with iron sequestration; and 150 (5%) with low iron stores. Iron status alterations were similar in women with haemoglobin < 130 g.l À1 or < 120 g.l
. For those who were not anaemic (n = 1898), corresponding figures were 656 (35%), 621 (33%), 165 (9%) and 518 (27%), respectively. Anaemia was present in one-third of patients undergoing major elective procedures. Over two-thirds of anaemic patients presented with absolute iron deficiency or iron sequestration. Over half of non-anaemic patients presented with absolute iron deficiency or low iron stores. We consider these data useful for planning pre-operative management of patients scheduled for major elective surgery.
Introduction
During major elective surgery, patients may be exposed to the effects of pre-operative anaemia, blood loss and red cell transfusion, all of which may adversely influence postoperative infection rates, length of hospital stay and mortality [1] . There is no agreement on their relative contributions to poor outcomes, but the effects seem to be synergistic [2] .
Pre-operative anaemia is a frequent condition, and is usually regarded as no more than a surrogate marker of the severity of the pathology requiring surgical treatment; many clinicians do not consider it to increase patient risk, and it is therefore not always adequately treated before surgery [3] . In contrast, a recent meta-analysis of over 900,000 patients who underwent major elective surgery has shown that preoperative anaemia, even if mild, is an independent risk factor for worse postoperative outcomes [4] . A sub-optimal haemoglobin level (< 130 g.l À1 for both sexes) is an independent predictive factor for peri-operative red cell transfusion [3] . During major elective surgery, peri-operative blood loss may lead to acute severe anaemia, especially in patients with low pre-operative haemoglobin. To avoid harm, red cell transfusions are usually administered, as they produce a quick, albeit transient, increase in haemoglobin levels. However, red cell transfusions carry risks, and there are significant variations in the proportion of patients who receive peri-operative transfusions when undergoing particular major surgical procedures in different centres [5, 6] . Iron deficiency is the most frequent cause of anaemia worldwide [7] , but a recent meta-analysis of 21 trials in different clinical settings concluded that there is emerging evidence that non-anaemic iron deficiency is a disease in its own right [8] . Low iron stores may hamper pre-operative haemoglobin optimisation, and have been linked to increased transfusion requirements and postoperative complications in major surgery [9] [10] [11] . Therefore, non-anaemic iron deficiency and low iron stores require pre-operative detection and treatment [12] [13] [14] .
Stimulation of erythropoiesis to optimise pre-operative haemoglobin, and correction of iron and other haematinic deficiencies constitute the fundamental pillars of multidisciplinary and multimodal 'patient blood management' (PBM) programmes, aimed at ensuring continuity of care to improve clinical outcomes [15] . However, these present logistical problems, highlighting the difficulties that arise in implementing guideline recommendations into daily clinical practice [3, 16] .
A first step towards effectively implementing a pre-operative anaemia management protocol is knowledge of the prevalence and causes of anaemia, which this study aimed to address.
Methods
We performed a retrospective analysis of pooled clinical and analytical data, in a large cohort of consecutive patients undergoing common major elective procedures in five centres in Spain between January 2008 and December 2014. We selected procedures for which pre-operative anaemia due to underlying pathology is frequent, expected blood loss is > 500 ml and/or transfusion risk is > 10%. These included: knee or hip arthroplasty; lumbo-sacral spinal fusion (orthopaedic surgery); cardiac valve replacement, coronary revascularisation or both (cardiac surgery with cardiopulmonary bypass); colorectal cancer resection; radical prostatectomy; hysterectomy with or without anexectomy (gynaecological surgery); and resection of liver metastases. This retrospective, observational study used only non-identifiable, disaggregated data, which maintained confidentiality, and was authorised by the local ethics committee or the Caldicott Guardian equivalent from the participating centres.
We collected baseline characteristics, clinical and laboratory data. These included: age; weight; sex; type of surgery; haemoglobin level; reticulocyte count; iron, ferritin, transferrin and transferrin saturation; C-reactive protein; and vitamin B 12 and folate levels.
We defined pre-operative anaemia as a haemoglobin level < 130 g.l À1 for both sexes. Anaemia was subclassified as mild-to-moderate (100-129 g.l
À1
), or moderate-to-severe (< 100 g.l
). We defined absolute iron deficiency, with or without anaemia, as a serum ferritin level < 30 lg.l À1 [17] .
However, in the presence of inflammation (C-reactive protein > 5 mg.l À1 ), and/or transferrin saturation < 20%, a ferritin < 100 lg.l À1 cut-off was used for identification of absolute iron deficiency [18] [19] [20] . A ferritin < 100 lg.l À1 and transferrin saturation > 20%
indicates low iron stores for surgery during which moderate-to-high blood loss is expected [12, 18, 20] . In contrast, a ferritin > 100 lg.l À1 and transferrin saturation < 20% usually indicate iron sequestration, resulting in decreased iron availability, especially in the presence of inflammatory conditions [18] [19] [20] . Low levels of erythroid maturation factors were defined by serum a vitamin B 12 level < 200 pg.ml À1 and/or serum folate level < 4 ng.ml À1 [21] .
We used Pearson's chi-square test or Fisher's exact test for comparison of qualitative variables, and unpaired Student's t-test for comparison of quantitative variables, after testing for normality using the Kolmogorov-Smirnov test. All statistical analyses were performed using IBM-SPSS statistics 22 (Licensed to the University of M alaga, Spain). All p values reported are two-sided, and we considered p < 0.05 to be statistically significant.
Results
We analysed data from a total of 3342 patients (44.5% female) who underwent different major elective procedures (Table 1) . We classified 1212 (36.2%) patients as anaemic, using a haemoglobin cut-off of 130 g.l À1 for both sexes (Table 1) . Anaemia was mild-to-moderate (haemoglobin 100-119 g.l
À1
) in most cases, with significant differences in prevalence and severity of anaemia, according to the type of surgery (Fig. 1) . The highest prevalence of pre-operative anaemia was found in patients undergoing colorectal cancer resection and gynaecological surgery, for both mild-to-moderate and moderate-to-severe anaemia (haemoglobin < 100 g.l À1 ) (Fig. 1) . The lowest prevalence of anaemia was found in patients undergoing radical prostatectomy (Fig. 1) . Additionally, there were within-group differences in the prevalence of pre-operative anaemia for different orthopaedic surgical procedures (p = 0.002; Table 1 ).
Some iron parameters were available for 3070 patients. There were differences in the mean values of iron parameters between anaemic and non-anaemic patients ( Table 2 ). Parameters allowing classification of iron status were available for 2884 patients (Fig. 2) . Of 1898 non-anaemic patients (65.4% male), 32.7% presented with absolute iron deficiency, 8.7% with iron sequestration and 27.3% with low iron stores (Fig. 2) . The relative distribution of iron status differed according the type of surgery (Fig. 3a) . Absolute iron deficiency was more frequent in patients undergoing colorectal cancer resection, gynaecological surgery or resection of liver metastases than in other types of surgery (Fig. 3a) . The prevalence of iron sequestration and low iron stores was similarly distributed among the different surgical procedures, except for gynaecological surgery (Fig. 3a) . In contrast, among 986 patients who were anaemic (68.9% female), 61.6% presented with absolute iron deficiency, 10.2% with iron sequestration and 15.2% with low iron stores (Fig. 2) . The relative distribution of iron status alterations differed according the type of surgery (Fig. 3b) . Absolute iron deficiency was more frequent in patients undergoing colorectal cancer resection or gynaecological surgery than in other types of surgery (Fig. 3b) . Again, the prevalence of iron sequestration was similarly distributed among the different surgical procedures, except for gynaecological surgery (Fig. 3b) . Interestingly, the presence of low iron stores was also frequent among patients whose anaemia was not caused by iron deficiency, especially in orthopaedic surgery (Fig. 3b) . For the whole patient series, the prevalence of low iron stores was higher in non-anaemic than in anaemic patients (27.3% vs. 15.2%, respectively; p = 0.001; Fig. 3a and b) .
According to the World Health Organization definition for anaemia in non-pregnant women at sea level (haemoglobin level < 120 g.l À1 ) [22] , 416 patients out of 1486 (28%) presented with pre-operative anaemia. Additionally, 346 out of 1486 (23%) presented with haemoglobin levels of 120-129 g.l
. As we used a haemoglobin < 130 g.l À1 as a cut-off for defining anaemia in all patients (men and women), we compared iron parameters and iron status in women according to two haemoglobin cut-off points (< 120 g.l À1 and
). As depicted in Fig. 4 , the prevalence of iron status alterations (absolute iron deficiency, iron sequestration and low iron stores) in both haemoglobin groups was high, and slightly higher (with the exception of low iron stores) by less than 10% among those with haemoglobin < 120 g.l
. Levels of erythroid maturation factors were only available for 933 patients, and low vitamin B 12 and folate levels were observed in approximately 10% of them, with a trend towards a higher prevalence among those patients who were not anaemic ( Table 2) .
Discussion
Pre-operative anaemia is present in one-third of patients scheduled for major elective surgery. Up to two-thirds of anaemic patients presented with absolute ; □ Haemoglobin < 100 g.l
À1
; p = 0.001 between groups. or functional iron deficiency, and might have benefited from iron supplementation, with or without adjuvant erythropoietin administration (Fig. 2) . Over half of non-anaemic patients presented with absolute iron deficiency, or inadequate iron stores to recover from postoperative anaemia, and may also have benefited from iron supplementation (Fig. 2) . In contrast, vitamin B 12 and folic acid deficiency, with or without anaemia, affected less than 10% of screened patients. Overall, 80% of anaemic patients were successfully classified using iron and maturation factor levels, in accordance with recent recommendations [18] . These findings rely upon the definitions of anaemia and altered iron status that we used, which should be discussed. In major elective surgery, studies have shown that pre-operative screening for anaemia and appropriate intervention reduced transfusion requirements and improved outcomes [23] [24] [25] [26] [27] [28] [29] [30] . Failure to treat patients with pre-operative anaemia, thereby preventing avoidable transfusions, is equivalent to providing sub-optimal healthcare [31] . In most epidemiological studies [4, 32, 33] , pre-operative anaemia is defined using World Health Organization criteria (haemoglobin Figure 2 Patients' classification, according to pre-operative haemoglobin levels and iron status, and *suggested actions to be taken, as per a recent international consensus statement [18] . Absolute iron deficiency defined by ferritin < 30 lm.l À1 or ferritin 30-100 lm.l
, plus transferrin saturation < 20% and/or C-reactive protein > 5 mg.l À1 ; iron sequestration defined by ferritin > 100 lm.l
, plus transferrin saturation < 20% and/or C-reactive protein > 5 mg.l À1 ; low iron stores defined by ferritin 30-100 lm.l
, plus transferrin saturation > 20%.
< 130 g.l À1 in men, and < 120 g.l À1 in women) [22] .
However, for surgical procedures in which expected blood loss was > 500 ml and/or transfusion risk > 10%, we defined pre-operative anaemia as a haemoglobin < 130 g.l À1 for both sexes [3] . This definition is supported by a number of facts. First, women have lower circulating blood volumes than men, but similar blood loss when undergoing the same procedures. Therefore, when measured as a proportion of circulating blood volume, blood losses are proportionally higher in women, and may result in higher transfusion rates; this is corroborated by a large study in orthopaedic surgery [34] , and the first Austrian benchmark study [5] . In orthopaedic surgery, the risk of transfusion in women with a pre-operative haemoglobin of 120 g.l À1 was doubled compared with that in men with a haemoglobin of 130 g.l À1 [34] . In cardiac surgery, a 10 g.l À1 decrease in haemoglobin has been shown to be independently associated with increased transfusion requirements, increased mortality and prolonged hospital stay [6] . Secondly, we found that the prevalence of abnormal iron parameters and absolute iron deficiency among women with haemoglobin < 130 g.l À1 was slightly lower (by less than 10%) than among those with haemoglobin < 120 g.l
. In contrast, low iron stores were more prevalent among those with haemoglobin < 130 g.l À1 (Fig. 4) .
Thirdly, in Europe (but not in the UK), recombinant human erythropoietin administration is approved for reducing transfusion rates in patients with haemoglobin levels between 100 and 130 g.l À1 and adequate iron stores, who are scheduled for elective orthopaedic surgery, and expected to have moderate blood loss, irrespective of sex [35, 36] . In a large series of hip fracture repair surgery (n = 1443), a significant reduction in transfusion rates was observed for those patients (n = 305) presenting with haemoglobin concentrations between 120 g.l À1 and 130 g.l
, and who received perioperative intravenous iron sucrose (400-600 mg), with or without recombinant human erythropoietin (40.000 IU) [37] .
Therefore, a haemoglobin level < 130 g.l À1 should be considered to be sub-optimal for women in these surgical settings, and the appropriate target for pre-operative haemoglobin optimisation is a level ≥ 130 g.l
, to minimise the risk of transfusion and poor outcomes [3] .
Our definitions of iron status require clarification. Firstly, although most clinical laboratories use a lower cut-off level for serum ferritin (< 15-25 lg.l À1 ) [38] , we used a level < 30 lg.l
, because it is the most sensitive (92%) and specific (98%) cut-off level for the identification of absolute iron deficiency, with or without anaemia; for a patient with serum ferritin level < 30 lg.l À1 no further laboratory work-up is needed [17] . In the presence of inflammation (C-reactive protein > 5 mg.l ).
iron deficiency complicating the course of anaemia of chronic disease [18] [19] [20] .
Secondly, inflammation-induced iron sequestration (also called iron-restricted erythropoiesis) is characterised by low transferrin saturation in the presence of normal-to-high ferritin levels (> 100 lg.l
) [18] [19] [20] . However, a serum ferritin level > 100 lg.l À1 does not completely exclude iron deficiency in the setting of inflammation. In congestive heart failure, iron deficiency, as defined by ferritin < 100 lg.l
, or 100-299 lg.l À1 with a transferrin saturation < 20%, was independently associated with compromised physical performance and quality of life, as well as with an increase in all-cause and cardiovascular mortality [39, 40] . Other tests, such as a low reticulocyte haemoglobin content (< 28 pg), high proportion of hypochromic red cells (> 5%), or high ratio of serum transferrin receptor to the log of ferritin (> 2) can be utilised to diagnose a component of iron deficiency [19, 20] . In cardiac surgery, it has recently been shown that low red cell haemoglobin density (> 6%) was superior to hepcidin and bone marrow iron stores in identifying patients with anaemia of chronic disease and associated iron deficiency who would potentially benefit from parenteral iron therapy [41] . Thirdly, in the absence of inflammation, 1 lg.l
of serum ferritin reflects 8 mg of stored iron, whereas 200-250 mg iron is required to elevate haemoglobin by 10 g.l
. Thus, non-anaemic patients with low ferritin levels < 100 lg.l À1 (low iron stores), who are undergoing surgical procedures with moderate-to-high blood loss, do not have enough stored iron to replenish peri-operative haemoglobin loss and maintain normal iron stores, and may benefit from pre-operative iron administration [12, 14, 25, 27, 42] . Other nutrient deficiencies without anaemia should also be corrected [13] . To simplify care, 1 mg vitamin B 12 intramuscularly plus 5 mg.day À1 oral folic acid can be administered to treat for any possible deficiency [43] . We acknowledge the limitations of a retrospective, descriptive study of standard laboratory data from consecutive patients, who underwent common major elective surgical procedures at different time periods in different centres. It would have been interesting to have matched these data with clinical outcomes, including the need for transfusion, hospital length of stay and 30-90 day mortality, in the different groups: anaemic and iron deficient; anaemic and non-iron deficient; non-anaemic and iron deficient; non-anaemic and non-iron deficient. However, differences in the peri-operative management of these patient populations at the different centres (use of oral or intravenous iron, erythropoietin, autologous blood donation, cell salvage, antifibrinolytics, etc.) would have made it difficult to draw meaningful conclusions. We believe that our study provides a clear picture of pre-operative haemoglobin levels and iron status in patients undergoing major elective surgery. Therefore, the present data may be useful for designing pre-operative management strategies aimed at optimising pre-operative erythropoiesis in these surgical patient populations, according to the type of haematinic deficiency detected and the time available (Fig. 2) [18] . Figure 4 Alterations in iron status in female patients, according to pre-operative haemoglobin groups. □ Haemoglobin < 120 g.l À1 (n = 416); ■ Haemoglobin < 130 g.l À1 (n = 762). *p = 0.07; **p = 0.001.
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